Houston, Texas 77027


Purpose:

A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Methodology Development Environmental Clinical Trial with Reproxalap Ophthalmic Solutions (0.25% and 0.5%) in Subjects with Seasonal Allergic Conjunctivitis.


Criteria:

Inclusion Criteria: - be at least 18 years of age of either gender and any race - have a positive history of ocular allergies and a positive skin test reaction to ragweed pollen as confirmed by the allergic skin test given to the subject within 24 months of the subject's Visit 1 - have a calculated visual acuity of 0.7 logMAR or better in each eye as measured using an ETDRS chart Exclusion Criteria: - have known contraindications or sensitivities to the use of any of the investigational product medication or components - have any ocular condition that, in the opinion of the investigator, could affect the subject's safety or trial parameters (including but not limited to narrow angle glaucoma, clinically significant blepharitis, follicular conjunctivitis, iritis, pterygium, or a diagnosis of dry eye) - have had ocular surgical intervention within three months prior to Visit 1, or during the trial, or a history of refractive surgery six months prior to Visit 1, or have systemic surgery planned during the clinical trial or within 30 days after; - have a known history of retinal detachment, diabetic retinopathy, or active retinal disease - have an active ocular infection (bacterial, viral or fungal), active uveitis, or positive history of an ocular herpetic infection at any visit; - be a female who is currently pregnant, planning a pregnancy, or lactating


NCT ID:

NCT03660878


Primary Contact:

Bill Cavanagh
Phone: 781-761-4904
Email: bcavanagh@aldeyra.com


Backup Contact:

N/A


Location Contact:

Houston, Texas 77027
United States

Stephen G. Slade, MD

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.